Avenue Therapeutics (ATXI) Price to Sales (2025 - 2026)
Avenue Therapeutics' Price to Sales was 0.66 in Q2 2026, up 44.9% from 0.45 a year earlier.
Powered by 
Analysis
Avenue Therapeutics (ATXI) Price to Sales (2025 - 2026) Analysis & Trends
For FY2025, Price to Sales at Avenue Therapeutics came in at 1.54.
- Quarterly Price to Sales has moved between 0.45 (Q2 2025) and 1.79 (Q3 2025) over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.49 Bn | 1,099.07 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.65 Bn | 555.51 Bn | 17.30 Bn |
| 3 | AbbVie | 505.44 Bn | 478.55 Bn | 12.70 Bn |
| 4 | Merck | 358.27 Bn | 312.65 Bn | 12.21 Bn |
| 5 | Novartis Ag | 291.57 Bn | 255.56 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.15 Bn | 238.84 Bn | 12.86 Bn |
| 7 | Amgen | 237.41 Bn | 192.81 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.01 Bn | 169.21 Bn | 6.22 Bn |
| 9 | Pfizer | 171.23 Bn | 117.87 Bn | 10.94 Bn |
| 10 | Avenue Therapeutics | 1.27 Mn | -9.65 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.66 |
| Dec 31, 2025 | 1.54 |
| Sep 30, 2025 | 1.79 |
| Jun 30, 2025 | 0.45 |
API Access
Avenue Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ATXI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ATXI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ATXI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();